Jounce Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
9/10
|
11.8 | 48.77 | -75.8% | 2.8 | +320.75% |
| P/S |
|
0.4979 | 33.77 | -98.53% |
|
|
| P/BV |
|
0.2229 | 4.83 | -95.38% |
|
|
| P/FCF |
|
-3.29 | 61 | -105.39% |
|
|
| Ev/Ebitda |
|
1.99 | -22.17 | -108.97% |
|
|
| Ev/S |
|
-1.22 | 22.57 | -105.39% |
|
|
| Ev/FCF |
|
3.35 | 68.76 | -95.13% |
|
|
| E/P |
|
-0.5199 | 0.0178 | -3025.11% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-61.16 | 4.97 | -1330.07% | -99.54 | -38.56% |
| ROE |
|
-25.03 | 9.61 | -360.38% |
|
|
| ROA |
|
-21.89 | 0.3443 | -6458.3% |
|
|
| ROIC |
|
-40.9 | 7.63 | -635.74% |
|
|
| ROS |
|
-62.07 | -25.17 | 146.6% |
|
|
| ROCE |
|
-27.64 | 15.45 | -278.93% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.1992 | -3.68 | -94.58% | 1.11 | -117.93% |
| Nеt Debt/Ebitda |
|
2.8 | -3.44 | -181.48% |
|
|
| Debt/Ratio |
|
0.047 | 0.1986 | -76.31% |
|
|
| Debt/Equity |
|
2.7 | 1.66 | 62.58% |
|
|
| Debt/Net Income |
|
-0.1965 | 10.32 | -101.9% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.541 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2256 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9598 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4928 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.541 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-44.56 | -57.64 | -22.69% | ||
| Growth impulse Ebitda in 5 years |
|
-195.08 | -90.94 | 114.52% | ||
| Growth impulse Net Income in 5 years |
|
-189.61 | -97.8 | 93.88% | ||
| Growth impulse FCF in 5 years |
|
-4.18 | -108.72 | -96.16% | ||
| Growth impulse EPS in 5 years |
|
17.21 | -142.05 | -112.12% |
IP Score
3.2/10
